ASSUT EUROPE SPA

ASSUT Europe SPA specializes in surgical sutures, producing both bioabsorbable and non-bioabsorbable variants. Their portfolio includes polyester sutures (monofilament and multifilament, non-antimicrobial), barbed polyester sutures, barbed polyolefin sutures, and polyolefin/fluoropolymer monofilament sutures. These are designed for tissue approximation and fixation in surgical procedures, with variations tailored for specific clinical needs like faster absorption or enhanced handling.

ASSUT Europe SPA is headquartered in Italy, which means its devices must comply with EU Medical Device Regulations (MDR) or the Medical Device Directive (MDD) depending on the applicable timeline. The company’s products are listed in the EUDAMED registry, confirming their registration under EU requirements. Additionally, some devices are included in the FDA’s UDI system, indicating they are also marketed in the U.S. under FDA oversight.

ASSUT Europe SPA’s devices are listed in the EUDAMED registry (European database for medical devices) and the FDA’s UDI system (Unique Device Identifier). EUDAMED ensures transparency and traceability of devices under EU regulations, while the FDA’s UDI system provides a standardized way to identify medical devices in the U.S., improving patient safety and regulatory tracking. Listing in these systems confirms compliance with respective jurisdictions’ requirements.

ASSUT Europe SPA’s sutures are classified as EU Class II or Class III devices. Class II devices typically pose a moderate risk (e.g., sutures requiring special controls to ensure safety and performance), while Class III devices involve higher risks (e.g., those used in life-supporting or life-sustaining procedures). This classification determines the regulatory scrutiny, clinical evidence requirements, and post-market surveillance obligations the manufacturer must meet to ensure their devices remain safe and effective for surgical use.